G8, CARG, Frailty, and Nutritional Markers in Predicting Chemotoxicity
N/A
This study aims to evaluate the ability of G8, CARG, and Frailty scales to ...
Status
Active Not Recruiting
Location
Çanakkale Onsekiz Mart Univercity
Start Date
2025-01-02
Trial ID
NCT07151794
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
PHASE2
This study will treat participants with newly diagnosed, low, intermediate ...
A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old
PHASE3
The study will include newly-diagnosed AML patients, not suffering acute pr...
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
PHASE1
This phase I trial tests the safety and side effects of B-cell activating f...
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
PHASE3
This randomized phase III trial studies how well gemcitabine hydrochloride ...
Cognitive Health in Ageing Register: Investigational and Observational Trial Studies in Dementia Research (CHARIOT): Prospective Readiness Cohort (PRO) Longitudinal Study
N/A
Alzheimer's disease is a degenerative condition affecting the brain and is ...
Status
Recruiting
Location
Imperial College London
Start Date
2025-03-17
Trial ID
NCT06953167
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
PHASE1
This phase I/II trial studies the safety, side effects, and best dose of de...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium